Synergy PharmaceuticalsAnother stock in the biotechnology and drugs complex that's setting up for a major breakout trade is Synergy Pharmaceuticals (SGYP), which focuses primarily on the development of drugs to treat gastrointestinal disorders and diseases in the U.S. This stock is off to a decent start in 2012, with shares up over 30% so far.
5 Biotech Stocks Poised for Breakouts
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts